QT
GPCR icon

Quantbot Technologies’s Structure Therapeutics GPCR Stock Holding History

Quantbot Technologies’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,888
Closed -$59.9K – 1886
2025
Q2 		$59.9K Sell
2,888
-11,513
-80% -$253K ﹤0.01% 1472
2025
Q1 		$249K Buy
+14,401
New +$353K 0.01% 1083
2024
Q3 		– Sell
-7,105
Closed -$279K – 1594
2024
Q2 		$279K Buy
+7,105
New +$292K 0.01% 892

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quantbot Technologies's GPCR Position: Q3 2025 in Review

Quantbot Technologies sold out of Structure Therapeutics (GPCR) in Q3 2025, closing a stake of 2,888 shares — an estimated $59.9K sold.

Quantbot Technologies first reported a position in GPCR in Q2 2024 and held it in 3 quarters. The position peaked at $279K in Q2 2024. 156 funds tracked by Wall St. Rank hold GPCR as of Q3 2025.

  • Quantbot Technologies reported no remaining Structure Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Quantbot Technologies sold 2,888 Structure Therapeutics shares in Q3 2025, an estimated $59.9K.
  • Quantbot Technologies first reported a position in Structure Therapeutics in Q2 2024 and held it in 3 quarters.
  • Quantbot Technologies's Structure Therapeutics position peaked at $279K in Q2 2024.
  • 156 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2025.

Based on Quantbot Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.